Glucotrack closes $10 million underwritten public offering of common stock

Rutherford, nj, april 17, 2023 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced the closing of a firm commitment underwritten public offering of shares of its common stock with gross proceeds to the company expected to be approximately $10.0 million, before deducting underwriting discounts and other estimated expenses payable by the company. the offering consisted of 7,352,942 shares of common stock and pre-funded warrants to purchase shares of common stock at a price to the public of $1.36 per share (less $0.001 in exercise price per pre-funded warrant).
GCTK Ratings Summary
GCTK Quant Ranking